Zenith Drugs Limited (NSE:ZENITHDRUG)

India flag India · Delayed Price · Currency is INR
39.65
-1.20 (-2.94%)
Apr 29, 2026, 3:19 PM IST
-49.10%
Market Cap 700.53M
Revenue (ttm) 1.44B
Net Income (ttm) 37.77M
Shares Out 17.15M
EPS (ttm) 2.20
PE Ratio 18.57
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,400
Average Volume 7,880
Open 41.00
Previous Close 40.85
Day's Range 38.25 - 41.00
52-Week Range 33.30 - 84.65
Beta 1.48
RSI 40.63
Earnings Date May 29, 2026

About Zenith Drugs

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated i... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1956
Employees 182
Stock Exchange National Stock Exchange of India
Ticker Symbol ZENITHDRUG
Full Company Profile

Financial Performance

In fiscal year 2025, Zenith Drugs's revenue was 1.33 billion, an increase of 1.29% compared to the previous year's 1.32 billion. Earnings were 71.61 million, a decrease of -24.92%.

Financial Statements

News

There is no news available yet.